Quick Answer
Aura Biosciences, Inc. reported Net Income of -$106.19 million for fiscal year 2025.
Aura Biosciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$106.19M | -22.2% |
| 2024 | -$86.92M | -13.8% |
| 2023 | -$76.41M | -30.0% |
| 2022 | -$58.76M | -66.7% |
| 2021 | -$35.25M | -58.7% |
| 2020 | -$22.21M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$26.13M | -24.2% | +3.3% |
| June 30, 2025 | -$27.02M | -32.9% | +1.7% |
| March 31, 2025 | -$27.48M | -39.5% | -30.6% |
| September 30, 2024 | -$21.04M | -13.7% | -3.5% |
| June 30, 2024 | -$20.34M | -11.1% | -3.2% |
| March 31, 2024 | -$19.71M | -12.8% | -6.4% |
| September 30, 2023 | -$18.51M | -16.4% | -1.2% |
| June 30, 2023 | -$18.30M | -35.9% | -4.8% |
- Aura Biosciences, Inc. showed a decrease of -22.2% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Aura Biosciences, Inc.’s net income has declined by 378.2% (from -$22.21 million to -$106.19 million).
- The most recent figure is from Aura Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: